The 26S proteasome drives trinucleotide repeat expansions

Nucleic Acids Research

Volumn 41, Issue 12, 2013, Pages 6098-6108

  Concannon, Claire ^a   Lahue, Robert S ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEASOME; REGULATOR PROTEIN; SEM1 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CAG REPEAT; CELL EXPANSION; COMPLEX FORMATION; CONTROLLED STUDY; GENE DELETION; GENE INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATOR GENE; SEM1 GENE; TRINUCLEOTIDE REPEAT; YEAST CELL;

ASTROCYTES; CELLS, CULTURED; HUMANS; MUTATION; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION; UBIQUITIN;

EID: 84880215877     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt295     Document Type: Article

References (77)

1. Orr, H.T. and Zoghbi, H.Y. (2007) Trinucleotide repeat disorders. Annu. Rev. Neurosci., 30, 575-621.
2. Mirkin, S.M. (2007) Expandable DNA repeats and human disease. Nature, 447, 932-940.
3. Lopez Castel, A., Cleary, J.D. and Pearson, C.E. (2010) Repeat instability as the basis for human diseases and as a potential target for therapy. Nat. Rev. Mol. Cell. Biol., 11, 165-170.
4. McMurray, C.T. (2010) Mechanisms of trinucleotide repeat instability during human development. Nat. Rev. Genet., 11, 786-799.
5. Paulson, H.L. and Fischbeck, K.H. (1996) Trinucleotide repeats in neurogenetic disorders. Annu. Rev. Neurosci., 19, 79-107.
6. Lahue, R.S. and Slater, D.L. (2003) DNA repair and trinucleotide repeat instability. Front. Biosci., 8, s553-s565.
7. McMurray, C.T. (2008) Hijacking of the mismatch repair system to cause CAG expansion and cell death in neurodegenerative disease. DNA Repair, 7, 1121-1134.
8. Manley, K., Shirley, T.L., Flaherty, L. and Messer, A. (1999) Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nat. Genet., 23, 471-473.
9. Kovtun, I.V. and McMurray, C.T. (2001) Trinucleotide expansion in haploid germ cells by gap repair. Nat. Genet., 27, 407-411.
10. van den Broek, W.J., Nelen, M.R., Wansink, D.G., Coerwinkel, M.M., te Riele, H., Groenen, P.J. and Wieringa, B. (2002) Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Hum. Mol. Genet., 11, 191-198.
11. Savouret, C, Brisson, E., Essers, J., Kanaar, R., Pastink, A., te Riele, H., Junien, C. and Gourdon, G (2003) CTG repeat instability and size variation timing in DNA repair-deficient mice. EMBO J., 22, 2264-2273.
12. Wheeler, V.C, Lebel, LA., Vrbanac, V., Teed, A., te Riele, H. and MacDonald, M.E. (2003) Mismatch repair gene Msh2 modifies the timing of early disease in HdhQ111 striatum. Hum. Mol. Genet., 12, 273-281.
13. Mollersen, L., Rowe, A.D., Illuzzi, J.L., Hildrestrand, GA., Gerhold, K.J., Tveteras, L., Bjolgerud, A., Wilson, D.M.III, Bjoras, M. and Klungland, A. (2012) Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice. Hum. Mol. Genet., 21, 4939-4947.
14. Gomes-Pereira, M., Fortune, M.T., Ingram, L., McAbney, J.P. and Monckton, D.G (2004) Pms2 is a genetic enhancer of trinucleotide CAG"CTG repeat somatic mosaicism: implications for the mechanism of triplet repeat expansion. Hum. Mol. Genet., 13, 1815-1825.
15. Kovtun, I.V., Liu, Y., Bjoras, M., Klungland, A., Wilson, S.H. and McMurray, CT. (2007) OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature, 447, 447-452.
16. Hubert, L. Jr, Lin, Y., Dion, V. and Wilson, J.H. (2011) Xpa deficiency reduces CAG trinucleotide repeat instability in neuronal tissues in a mouse model of SCA1. Hum. Mol. Genet., 20, 4822-4830.
17. Debacker, K., Frizzell, A., Gleeson, O., Kirkham-McCarthy, L., Mertz, T. and Lahue, R.S. (2012) Histone deacetylase complexes promote trinucleotide repeat expansions. PLoS Biol, 10, e1001257.
18. Gannon, A.M., Frizzell, A., Healy, E. and Lahue, R.S. (2012) MutSß and histone deacetylase complexes promote expansions of trinucleotide repeats in human cells. Nucleic Acids Res., 40, 10324-10333.
19. Lahue, R.S. and Frizzell, A. (2012) Histone deacetylase complexes as caretakers of genome stability. Epigenetics, 7, 806-810.
20. Lin, Y. and Wilson, J.H. (2007) Transcription-induced CAG repeat contraction in human cells is mediated in part by transcription-coupled nucleotide excision repair. Mol. Cell. Biol., 27, 6209-6217.
21. Finley, D., Ullrich, H.D., Sommer, T. and Kaiser, P. (2012) The ubiquitin-proteasome system of Saccharomyces cerevisiae. Genetics, 192, 319-360.
22. Reed, S.H. and Gillette, T.G (2007) Nucleotide excision repair and the ubiquitin proteasome pathway-do all roads lead to Rome? DNA Repair, 6, 149-156.
23. Ferdous, A., Gonzalez, F., Sun, L., Kodadek, T. and Johnston, SA. (2001) The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell, 7, 981-991.
24. Kodadek, T. (2010) No Splicing, no dicing: non-proteolytic roles of the ubiquitin-proteasome system in transcription. J. Biol. Chem., 285, 2221-2226.
25. Kwak, J., Workman, J.L. and Lee, D. (2011) The proteasome and its regulatory roles in gene expression. Biochim. Biophys. Acta, 1809, 88-96.
26. Lee, D., Ezhkova, E., Li, B., Pattenden, S.G, Tansey, W.P. and Workman, J.L. (2005) The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell, 123, 423-436.
27. Brachmann, C.B., Davies, A., Cost, GJ., Caputo, E., Li, J., Hieter, P. and Boeke, J.D. (1998) Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast, 14, 115-132.
28. Jamieson, D.J., Rivers, S.L. and Stephen, D.W. (1995) Analysis of Saccharomyces cerevisiae proteins induced by peroxide and superoxide stress. Microbiology, 140, 3277-3283.
29. Sone, T., Saeki, Y., Toh-e, A. and Yokosawa, H. (2004) Sem1p is a novel subunit of the 26 S proteasome from Saccharomyces cerevisiae. J. Biol. Chem., 279, 28807-28816.
30. Rolfsmeier, M.L., Dixon, M.J., Pessoa-Brandao, L., Pelletier, R., Miret, J.J. and Lahue, R.S. (2001) Cis-elements governing trinucleotide repeat instability in Saccharomyces cerevisiae. Genetics, 157, 1569-1579.
31. Dixon, M.J., Bhattacharyya, S. and Lahue, R.S. (2004) Genetic assays for triplet repeat instability in yeast. Methods Mol. Biol., 277, 29-45.
32. Lee, D.H. and Goldberg, A.L. (1996) Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae J. Biol. Chem., 271, 27280-27284.
33. Marston, N.J., Richards, W.J., Hughes, D., Bertwistle, D., Marshall, C.J. and Ashworth, A. (1999) Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol. Cell. Biol., 19, 4633-4642.
34. Wei, S.J., Williams, J.G., Dang, H., Darden, T.A., Betz, B.L., Humble, M.M., Chang, F.M., Trempus, C.S., Johnson, K., Cannon, R.E. et al. (2008) Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation. J. Mol. Biol., 383, 693-712.
35. Butler, L.R., Densham, R.M., Jia, J., Garvin, A.J., Stone, H.R., Shah, V., Weekes, D., Festy, F., Beesley, J. and Morris, J.R. (2012) The proteasomal de-ubiquitinating enzyme POH1 promotes the double-strand DNA break response. EMBO J., 31, 3918-3934.
36. Kristensen, C.N., Bystol, K.M., Serrano, L. and Brenneman, M.A. (2010) Depletion of DSS1 protein disables homologous recombinational repair in human cells. Mutat. Res., 694, 60-64.
37. Baelde, H.J., Eikmans, M., Lappin, D.W., Doran, P.P., Hohenadel, D., Brinkkoetter, P.T., van der Woude, F.J., Rabelink, T.J., de Heer, E. and Bruijn, J.A. (2007) Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int., 71, 637-645.
38. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods, 25, 402-408.
39. Funakoshi, M., Li, X., Velichutina, I., Hochstrasser, M. and Kobayashi, H. (2004) Sem1, the yeast ortholog of a human BRCA2-binding protein, is a component of the proteasome regulatory particle that enhances proteasome stability. J. Cell. Sci., 117, 6447-7457.
40. Collins, S.R., Miller, K.M., Maas, N.L., Roguev, A., Fillingham, J., Chu, C.S., Schuldiner, M., Gebbia, M., Recht, J., Shales, M. et al. (2007) Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map. Nature, 446, 806-810.
41. Wilmes, G.M., Bergkessel, M., Bandyopadhyay, S., Shales, M., Braberg, H., Cagney, G., Collins, S.R., Whitworth, G.B., Kress, T.L., Weissman, J.S. et al. (2008) A genetic interaction map of RNA-processing factors reveals links between Sem1/Dss1-containing complexes and mRNA export and splicing. Mol. Cell, 32, 735-746.
42. Zheng, J., Benschop, J.J., Shales, M., Kemmeren, P., Greenblatt, J., Cagney, G., Holstege, F., Li, H. and Krogan, N.J. (2010) Epistatic relationships reveal the functional organization of yeast transcription factors. Mol. Syst. Biol., 6, 420.
43. Pick, E., Hoffman, K. and Glickman, M.H. (2009) PCI complexes: beyond the proteasome, CNS, and eIF3 troika. Mol. Cell, 35, 260-264.
44. Qin, S., Wang, Q., Ray, A., Wani, G., Zhao, Q., Bhaumik, S.R. and Wani, A.A. (2009) Sem1p and Ubp6p orchestrate telomeric silencing by modulating histone H2B ubiquitination and H3 acetylation. Nucleic Acids Res., 37, 1843-1853.
45. Krogan, N.J., Lam, M.H., Fillingham, J., Keogh, M.C., Gebbia, M., Li, J., Datta, N., Cagney, G., Buratowski, S., Emili, A. et al. (2004) Proteasome involvement in the repair of DNA double-strand breaks. Mol. Cell, 16, 1027-1034.
46. Faza, M.B., Kemmler, S., Jimeno, S., Gonzalez-Aguilera, C, Aguilera, A., Hurt, E. and Panse, V.G. (2009) Sem1 is a functional component of the nuclear pore complex-associated messenger RNA export machinery. J. Cell Biol., 184, 833-846.
47. Velichutina, I., Connerly, P.L., Arendt, C.S., Li, X. and Hochstrasser, M. (2004) Plasticity in eucaryotic 20S proteasome ring assembly revealed by a subunit deletion in yeast. EMBO J., 23, 500-510.
48. Major, E.O., Miller, A.E., Mourrain, P., Traub, R.G., de Widt, E. and Sever, J. (1985) Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl Acad. Sci. USA, 82, 1257-1261.
49. Gee, GV., Manley, K. and Atwood, W.J. (2003) Derivation of a JC virus-resistant human glial cell line: implications for the identification of host cell factors that determine viral tropism. Virology, 314, 101-109.
50. Claassen, DA. and Lahue, R.S. (2007) Expansions of CAG"CTG repeats in immortalized human astrocytes. Hum. Mol. Genet., 16, 3088-3096.
51. Jacquemont, C. and Taniguchi, T. (2007) Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res., 67, 7395-7405.
52. Wang, W., Chevray, P.M. and Nathans, D. (1996) Mammalian Sug1 and c-Fos in the nuclear 26S proteasome. Proc. Natl Acad. Sci. USA, 93, 8236-8240.
53. Rubin, D.M., Coux, O., Wefes, I., Hengartner, C, Young, RA., Goldberg, A.L. and Finley, D. (1996) Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome. Nature, 379, 655-657.
54. Coux, O., Tanaka, K. and Goldberg, A.L. (1996) Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem., 65, 801-847.
55. Yamada, H.Y. and Gorbsky, GJ. (2006) Inhibition of TRIP1/S8/hSug1, a component of the human 19S proteasome, enhances mitotic apoptosis induced by spindle poisons. Mol. Cancer Ther., 5, 29-38.
56. Koues, O.I., Dudley, R.K., Mehta, N.T. and Greer, S.F. (2009) The 19S proteasome positively regulates histone methylation at cytokine inducible genes. Biochim. Biophys. Acta, 1789, 691-701.
57. Hanna, J., Meides, A., Zhang, D.P. and Finley, D. (2007) A ubiquitin stress response induces altered proteasome composition. Cell, 129, 747-759.
58. Leggett, D.S., Hanna, J., Borodovsky, A., Crosas, B., Schmidt, M., Baker, R.T., Walz, T., Ploegh, H. and Finley, D. (2002) Multiple associated proteins regulate proteasome structure and function. Mol. Cell, 10, 495-507.
59. Hanna, J., Leggett, D.S. and Finley, D. (2003) Ubiquitin depletion as a key mediator of toxicity by translational inhibitors. Mol. Cell. Biol., 23, 9251-9261.
60. London, M.K., Keck, B.I., Ramos, P.C. and Dohmen, R.J. (2004) Regulatory mechanisms controlling biogenesis of ubiquitin and the proteasome. FEBS Lett., 567, 259-264.
61. Saeki, Y., Saitoh, A., Toh-e, A. and Yokosawa, H. (2002) Ubiquitin-like proteins and Rpn10 play cooperative roles in ubiquitin-dependent proteolysis. Biochem. Biophys. Res. Commun., 293, 986-992.
62. Verma, R., Oania, R., Graumann, J. and Deshaies, R.J. (2004) Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system. Cell, 118, 99-110.
63. Elangovan, M., Oh, C, Sukumaran, L., Wojcik, C. and Yoo, Y.J. (2010) Functional differences between two major ubiquitin receptors in the proteasome; S5a and hRpn13. Biochem. Biophys. Res. Commun., 396, 425-428.
64. Koues, O.I., Dudley, R.K., Truax, A.D., Gerhardt, D., Bhat, K.P., McNeal, S. and Greer, S.F. (2008) Regulation of acetylation at the major histocompatibility complex class II proximal promoter by the 19S proteasomal ATPase Sug1. Mol. Cell. Biol., 28, 5837-5850.
65. Yang, H., Jeffrey, P.D., Miller, J., Kinnucan, E., Sun, Y., Thoma, N.H., Zheng, N, Chen, P.L., Lee, W.H. and Pavletich, N.P. (2002) BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science, 297, 1837-1848.
66. Li, J., Zou, C, Bai, Y., Wazer, D.E., Band, V. and Gao, Q. (2006) DSS1 is required for the stability of BRCA2. Oncogene, 25, 1186-1194.
67. Motegi, A., Murakawa, Y. and Takeda, S. (2009) The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy. Cancer Lett., 283, 1-9.
68. Kouranti, I. and Peyroche, A. (2012) Protein degradation in DNA damage response. Semin. Cell Dev. Biol., 23, 538-545.
69. Grabczyk, E., Mancuso, M. and Sammarco, M.C. (2007) A persistent RNA.DNA hybrid formed by transcription of the Friedreich ataxia triplet repeat in live bacteria, and by T7 RNAP in vitro. Nucleic Acids Res., 35, 5351-5359.
70. Lin, Y., Dent, S.Y., Wilson, J.H., Wells, R.D. and Napierala, M. (2010) R loops stimulate genetic instability of CTG.CAG repeats. Proc. Natl Acad. Sci. USA, 107, 692-697.
71. Reddy, K., Tam, M., Bowater, R.P., Barber, M., Tomlinson, M., Nichol Edamura, K., Wang, Y.H. and Pearson, C.E. (2011) Determinants of R-loop formation at convergent bidirectionally transcribed trinucleotide repeats. Nucleic Acids Res., 39, 1749-1762.
72. Goula, A.V., Pearson, C.E., Della Maria, J., Trottier, Y., Tomkinson, A.E., Wilson, D.M.III and Merienne, K. (2012) The nucleotide sequence, DNA damage location, and protein stoichiometry influence the base excision repair outcome at CAG/CTG repeats. Biochemistry, 51, 3919-3932.
73. Somesh, B.P., Reid, J., Liu, W.F., Sogaard, T.M., Erdjument-Bromage, H., Tempst, P. and Svejstrup, J.Q. (2005) Multiple mechanisms confining RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest. Cell, 121, 913-923.
74. Lin, Y. and Wilson, J.H. (2012) Nucleotide excision repair, mismatch repair, and R-loops modulate convergent transcription-induced cell death and repeat instability. PLoS One, 7, e46807.
75. Schipper-Krom, S., Juenemann, K. and Reits, E.A. (2012) The Ubiquitin-Proteasome System in Huntington's disease: are proteasomes impaired, initiators of disease, or coming to the rescue? Biochem. Res. Int., 2012, Article ID: 837015.
76. Lin, J.T., Chang, W.C., Chen, H.M., Lai, H.L., Chen, C.Y., Tao, M.H. and Chern, Y. (2013) Regulation of feedback between protein kinase a and the proteasome system worsens Huntington's disease Mol. Cell. Biol., 33, 1073-1084.
77. Mattern, M.R., Wu, J. and Nicholson, B. (2012) Ubiquitin-based anticancer therapy: carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors. Biochim. Biophys. Acta, 1823, 2014-2021.